Public Profile

SHL Medical

SHL Medical, headquartered in Switzerland (CH), is a leading player in the medical device industry, specialising in the development and manufacturing of innovative drug delivery systems. Founded in 1980, the company has established a strong presence in Europe, North America, and Asia, focusing on enhancing patient care through advanced technology. With a commitment to quality and precision, SHL Medical offers a range of core products, including auto-injectors and pen injectors, designed to improve the administration of biologics and other medications. Their unique approach combines user-centric design with robust engineering, ensuring reliability and ease of use. Recognised for its excellence, SHL Medical has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical companies worldwide. The company’s dedication to innovation and quality has solidified its reputation as a leader in the drug delivery market.

DitchCarbon Score

How does SHL Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

6

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

8

Industry Benchmark

SHL Medical's score of 6 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.

79%

SHL Medical's reported carbon emissions

SHL Medical, headquartered in Switzerland (CH), currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company is likely to be aware of the growing importance of sustainability in the medical device industry and may be exploring strategies to address carbon emissions in line with global climate goals. As the industry evolves, SHL Medical's future commitments and actions will be crucial in contributing to a more sustainable environment.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. SHL Medical's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. SHL Medical is headquartered in CH, which has a rank of very low, indicating very low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

SHL Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Research Services

SANDERSON WEATHERALL LTD

GB
Research Services
Updated 11 days ago

Gulf Center Cosmetics Manufacturing

AE
Research Services
Updated 11 days ago

Aquabounty Technologies

US
Research Services
Updated 11 days ago

Lepu Biopharma

CN
Research Services
Updated 11 days ago

Biomega

NO
Research Services
Updated 11 days ago

Health Research Services Ltd

GB
Research Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers